{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:17:06Z","timestamp":1778073426412,"version":"3.51.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,6]]},"DOI":"10.7759\/cureus.108355","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:31:01Z","timestamp":1778070661000},"source":"Crossref","is-referenced-by-count":0,"title":["Pembrolizumab Failure in an Aggressive, Platinum-Resistant Primary Mediastinal Yolk Sac Tumor With Rapid Metastatic Dissemination, Spinal Cord Compression, and a Fatal Outcome"],"prefix":"10.7759","author":[{"given":"Salah","family":"Riyadh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garred","family":"Cline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.21037\/med-21-22","article-title":"Mediastinal germ cell tumors: a narrative review of their traits and aggressiveness features","volume":"6","author":"Pini GM","year":"2022","unstructured":"Pini GM, Colecchia M. Mediastinal germ cell tumors: a narrative review of their traits and aggressiveness features. Mediastinum. 2022, 6:5. 10.21037\/med-21-22","journal-title":"Mediastinum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.07.062","article-title":"Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis","volume":"20","author":"Bokemeyer C","year":"2002","unstructured":"Bokemeyer C, Nichols CR, Droz JP, et al.. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis. J Clin Oncol. 2002, 20:1864-73. 10.1200\/JCO.2002.07.062","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0430","article-title":"Genomic features for therapeutic insights of chemotherapy-resistant, primary mediastinal nonseminomatous germ cell tumors and comparison with gonadal counterpart","volume":"24","author":"Necchi A","year":"2019","unstructured":"Necchi A, Bratslavsky G, Chung J, Millis S, Gay LM, Ali SM, Ross JS. Genomic features for therapeutic insights of chemotherapy-resistant, primary mediastinal nonseminomatous germ cell tumors and comparison with gonadal counterpart. Oncologist. 2019, 24:e142-5. 10.1634\/theoncologist.2018-0430","journal-title":"Oncologist"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx680","article-title":"Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206","volume":"29","author":"Adra N","year":"2018","unstructured":"Adra N, Einhorn LH, Althouse SK, et al.. Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206. Ann Oncol. 2018, 29:209-14. 10.1093\/annonc\/mdx680","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020428","article-title":"The immune landscape and immunotherapeutic strategies in platinum-refractory testicular germ cell tumors","volume":"16","author":"Evmorfopoulos K","year":"2024","unstructured":"Evmorfopoulos K, Marsitopoulos K, Karachalios R, et al.. The immune landscape and immunotherapeutic strategies in platinum-refractory testicular germ cell tumors. Cancers (Basel). 2024, 16:428. 10.3390\/cancers16020428","journal-title":"Cancers (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0621","article-title":"Immunotherapy of ipilimumab and nivolumab in patients with advanced neuroendocrine tumors: a subgroup analysis of the CA209-538 clinical trial for rare cancers","volume":"26","author":"Klein O","year":"2020","unstructured":"Klein O, Kee D, Markman B, et al.. Immunotherapy of ipilimumab and nivolumab in patients with advanced neuroendocrine tumors: a subgroup analysis of the CA209-538 clinical trial for rare cancers. Clin Cancer Res. 2020, 26:4454-9. 10.1158\/1078-0432.CCR-20-0621","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.01.014","article-title":"A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression","volume":"84","author":"Loblaw DA","year":"2012","unstructured":"Loblaw DA, Mitera G, Ford M, Laperriere NJ. A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression. Int J Radiat Oncol Biol Phys. 2012, 84:312-7. 10.1016\/j.ijrobp.2012.01.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70089-9","article-title":"Metastatic epidural spinal cord compression","volume":"7","author":"Cole JS","year":"2008","unstructured":"Cole JS, Patchell RA. Metastatic epidural spinal cord compression. Lancet Neurol. 2008, 7:459-66. 10.1016\/S1474-4422(08)70089-9","journal-title":"Lancet Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S327342","article-title":"Clinicopathological features and prognosis of primary mediastinal malignant germ cell tumors: a retrospective single-institution analysis","volume":"13","author":"Zhang J","year":"2021","unstructured":"Zhang J, Chen Y, Liu L, Zhou M, Huang C, Guo C, Li S. Clinicopathological features and prognosis of primary mediastinal malignant germ cell tumors: a retrospective single-institution analysis. Cancer Manag Res. 2021, 13:8527-34. 10.2147\/CMAR.S327342","journal-title":"Cancer Manag Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/471476-pembrolizumab-failure-in-an-aggressive-platinum-resistant-primary-mediastinal-yolk-sac-tumor-with-rapid-metastatic-dissemination-spinal-cord-compression-and-a-fatal-outcome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:31:01Z","timestamp":1778070661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/471476-pembrolizumab-failure-in-an-aggressive-platinum-resistant-primary-mediastinal-yolk-sac-tumor-with-rapid-metastatic-dissemination-spinal-cord-compression-and-a-fatal-outcome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.108355","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,6]]}}}